Search Results - "Savoie, M.L"

Evaluation of HCT-CI Comorbidity Scores and Allogeneic Transplant Outcome of Young Adults After Myeloablative Conditioning with Fludarabine and Busulfan +/- TBI Malignancies by Slaby, J, Williamson, T, Chaudhry, A.M, Larratt, L, Turner, R.A, Bahlis, N.J, Brown, C.B, Daly, A, Duggan, P, Geddes, M, Quinlan, D, Savoie, M.L, Shafey, M, Storek, J, Yue, P, Zacarias, N, Stewart, D.A, Russell, J.A, Russell, J

Get full text

Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATG by El Kourashy, S, Williamson, T, Chaudhry, M A, Savoie, M L, Turner, A R, Larratt, L, Storek, J, Bahlis, N J, Brown, C B, Yang, M, Quinlan, D, Geddes, M, Zacarias, N, Daly, A, Duggan, P, Stewart, D A, Russell, J A

“…Non-myeloablative (MA) and reduced intensity allo-SCT regimens are offered to older patients and/or those with comorbidities because the morbidity and…”
Get full text

Shifting to outpatient management of acute myeloid leukemia: a prospective experience by Savoie, M. L., Nevil, T. J., Song, K. W., Forrest, D. L., Hogge, D. E., Nantel, S. H., Shepherd, J. D., Smith, C. A., Sutherland, H. J., Toze, C. L., Lavoie, J. C.

“…Background: We assessed the feasibility of outpatient chemotherapy and supportive care in patients with acute myeloid leukemia (AML). Patients and methods: All…”
Get full text

123A-locus mismatch does not adversely influence outcome following related-donor stem cell transplantation (SCT) by Savoie, M.L., Sutherland, H.J., Hogge, D.E., Nantel, S.H., Toze, C.L., Lavoie, J.C., Sheperd, J.D., Song, K., Forrest, D., Nevill, T.J.

Get full text